Skip to main content
. 2009 Sep 29;4(5):333–338. doi: 10.1159/000235888

Table 1.

Summary of results from several studies investigating the HER2 status of disseminated tumor cells (DTC) compared to their corresponding primary tumors

Author [Ref.] Patients, n Primary tumor HER2-positive, % DTC HER2-positive, % Concordance, %
Solomayer et al. [42] 45 14 (29) 20 (44) 63
Becker et al. [43] 105 26 (25) 22 (21) 77
Braun et al. [44] 24 7 (29) 15 (63) 58
Meng et al. [32] 33 15 (46) 11 (33) 88
Vincent-Salomon et al. [45] 27 5 (18.5) 4 (15) 90